MUTAGENICITY OF ACLACINOMYCIN-A AND DAUNOMYCIN DERIVATIVES
- 1 January 1978
- journal article
- research article
- Vol. 38 (6) , 1782-1784
Abstract
An antitumor antibiotic, aclacinomycin A, was nonmutagenic in a Salmonella test, but its derivative, N-demethylaclacinomycin A, was mutagenic. 1-Deoxypyromycin, a hydrolysis product of aclacinomycin A, was nonmutagenic, but N-demethyl-1-deoxypyrromycin was mutagenic. Daunomycin was highly mutagenic, but N-methyldaunomycin showed only weak mutagenicity, and N-dimethyldaunomycin was nonmutagenic. The aglycones of aclacinomycin A and daunomycin were not mutagenic. The amino moiety of anthracycline glycosides is concluded to be essential for mutagenesis.This publication has 5 references indexed in Scilit:
- ANTI-TUMOR ACTIVITY OF NEW ANTHRACYCLINE ANTIBIOTICS, ACLACINOMYCIN-A AND ITS ANALOGS, AND THEIR TOXICITY1977
- MUTAGENICITY OF CANCER CHEMOTHERAPEUTIC-AGENTS IN SALMONELLA-MICROSOME TEST1977
- Reductive cleavage of anthracycline glycosides by microsomal nadphcytochrome c reductase.The Journal of Antibiotics, 1977
- Production of nineteen anthracyclic compounds by Streptomyces galilaeus MA144-M1.The Journal of Antibiotics, 1977
- TUMORIGENICITY INVIVO AND INDUCTION OF MALIGNANT TRANSFORMATION AND MUTAGENESIS IN CELL-CULTURES BY ADRIAMYCIN AND DAUNOMYCIN1976